Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,777-1,788 of 4,306
Drug study icon
CompletedEUCTR 2012-004579-37

Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.
Countries
Czechia
Sponsor
National Institute of Mental Health
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2009-009235-30

Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
United Kingdom
Sponsor
Imperial College London
Condition
Schizophrenia
Biological study icon
CompletedEUCTR 2016-003529-41

CANGLIA: Endocannabinoid control of microglia activation as a new therapeutic target in the treatment of schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBiological
Countries
Netherlands
Sponsor
University Medical Center Utrecht
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2007-000579-40

Effects of atypical versus typical neuroleptics on motivation, hedonia, and social cognition in patients with schizophrenia – an fMRI study

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Germany
Sponsor
Charité Universitätsmedizin Berlin
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2018-001514-15

Effects of early clozapine treatment on remission rates in acute schizophrenia (EARLY)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Germany
Sponsor
Bezirkskliniken Schwaben
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2013-005451-32

Effects of F17464 in acute exacerbation of schizophrenia.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Hungary
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Hungary, Latvia, Romania
Sponsor
Pierre Fabre Médicament represented by the Institut de Recherche Pierre Fabre (IRPF)
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2008-002384-13

Efficacy and Tolerability of Flexible Doses of Paliperidone ER in Symptomatic Subjects with Schizophrenia with duration of illness < 10 years

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Italy
Sponsor
JANSSEN-CILAG
Condition
Schizophrenia
Biological study icon
CompletedEUCTR 2009-018054-33

Efficacy of vitamin E and omega-3 unsaturated fatty acid in prevention of damage induced by oxidative stress in patients with schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Slovenia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBiological
Countries
Slovenia
Sponsor
Faculty of Pharmacy, University of Ljubljana
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2010-018405-12

Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients with Schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Lithuania
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Lithuania
Sponsor
Forest Research Institute, Inc.
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2006-004891-10

Future strategies for vocational rehabilitation schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Germany
Sponsor
Charité - Universitätsmedizin Berlin
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2021-003816-20

IMPACT OF STRUCTURAL AND MYELIN ABNORMALITIES ON COGNITIVE IMPAIRMENTS IN RECENT-ONSET SCHIZOPHRENIA – before and after lurasidone treatment

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Italy
Sponsor
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.